Stock CPIX CUMBERLAND PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Cumberland Pharmaceuticals Inc.

Equities

CPIX

US2307701092

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.76 USD +3.53% Intraday chart for Cumberland Pharmaceuticals Inc. +10.00% -1.77%
Mar. 13 Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010. CI
Mar. 05 Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a prescription laxative, for the treatment of constipation, and Omeclamox-Pak, oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease. Its brands also include Sancuso transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia, and Vibativ injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia.

Number of employees: 91

Sales per Business

USD in Million2022Weight2023Weight Delta
Specialty Pharmaceutical Products
100.0 %
42 100.0 % 40 100.0 % -5.85%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
97.2 %
41 96.4 % 38 97.2 % -5.08%
Non-United States
2.8 %
2 3.6 % 1 2.8 % -26.67%

Managers

Managers TitleAgeSince
A. Kazimi CEO
 Chief Executive Officer 65 99-01-06
John Hamm DFI
 Director of Finance/CFO 67 18-12-31
James Herman CMP
 Compliance Officer 67 02-12-31
Gordon R. Bernard BRD
 Director/Board Member 72 99-01-05
Shayla Simpson IRC
 Investor Relations Contact - -
Chris Bitterman SAM
 Sales & Marketing 58 17-12-31
Kenny Acevedo SAM
 Sales & Marketing - 10-12-31
Adam Mostafa PRN
 Corporate Officer/Principal 44 16-12-31
Tan Cheow Choon PRN
 Corporate Officer/Principal - -
Todd Anthony PRN
 Corporate Officer/Principal - 09-12-31

Members of the board

Members of the board TitleAgeSince
Martin Brown BRD
 Director/Board Member 59 22-07-14
A. Kazimi CEO
 Chief Executive Officer 65 99-01-06
Ken Krogulski BRD
 Director/Board Member 66 17-01-17
Joseph Galante BRD
 Director/Board Member 74 18-09-18
Gordon R. Bernard BRD
 Director/Board Member 72 99-01-05
James Jones BRD
 Director/Board Member 76 09-12-31
Caroline Young BRD
 Director/Board Member 49 16-06-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 14,176,529 7,930,547 ( 55.94 %) 0 55.94 %

Shareholders

NameEquities%Valuation
A. Kazimi
40.18 %
5,695,557 40.18 % 10 M $
Renaissance Technologies LLC
3.879 %
549,863 3.879 % 923 770 $
Vanguard Group, Inc. (Subfiler)
2.640 %
374,251 2.640 % 628 742 $
Dimensional Fund Advisors LP
2.581 %
365,934 2.581 % 614 769 $
Bridgeway Capital Management LLC
2.022 %
286,655 2.022 % 481 580 $
Ken Krogulski
1.702 %
241,277 1.702 % 405 345 $
Acadian Asset Management LLC
1.327 %
188,164 1.327 % 316 116 $
BlackRock Institutional Trust Co. NA
0.7829 %
110,990 0.7829 % 186 463 $
Jacobs Joey Anthony /Estate Of/
0.6942 %
98,415 0.6942 % 165 337 $
Geode Capital Management LLC
0.6015 %
85,274 0.6015 % 143 260 $

Company contact information

Cumberland Pharmaceuticals, Inc.

1600 West End Avenue Suite 1300

37203, Nashville

+

http://www.cumberlandpharma.com
address Cumberland Pharmaceuticals Inc.(CPIX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
CUMBERLAND PHARMACEUTICALS INC. Stock Cumberland Pharmaceuticals Inc.
-1.77% 24.95M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CPIX Stock
  4. Company Cumberland Pharmaceuticals Inc.